MVMA QUARTERLY - SUMMER 2021
Ortu Stella Emerging Leader Nominations Due By August 15, 2021
(Heartworms cont. from page 9)
Additionally, the risk for Lyme disease, transmitted by ticks, continues to expand southward and westward with “hot spots” expected in portions of Michigan and Ohio, heightened risk persisting in the Northeast, and movement in to the southern states, including the Carolinas and Tennessee, CAPC reports.
At its Spring 2019 meeting, the MVMA Executive Board approved a new emerging leader recognition: the Ortu Stella Award (Latin for rising star). Nominations for the award will be suggested by the Recent Graduate and Collegiate Task Force, and any MVMA member who wishes to nominate a young veterinarian. The form to make nominations can be found at www.movma.org. Click on the “Volunteer” tab at top of main page.
“Because of the dynamic and everchanging nature of parasites, we started providing our annual forecasts more than nine years ago,” says the group’s CEO, Christopher Carpenter, DVM. “Over the years, we’ve seen the risk for parasitic diseases continue to increase and expand into areas that have had historically lower prevalence. CAPC’s 2021 Parasite Forecast is critical to alerting pet owners to the risks this year and reinforcing CAPC’s recommendation that all pets need to be annually tested and protected year-round.”
Nominators are responsible for securing and submitting biographical information and a statement reflecting the reasons they are making the nominaDr. Ken Vroman, left, presents tion. Any nominee must be an MVMA member the 2021 Ortu Stella Award to veterinarian in good standing, and not more than Dr. Jessica Stroups. ten years post receipt of their degree. The nominees will be selected by the Executive Board through an anonymous vote in relation to the degree to which they meet the following ideal: The Ortu Stella recipient must in some way shine brightly, aid comrades in navigating the veterinary profession, assist in illuminating the path for those around them, and/or demonstrate that they habitually strive to rise to the occasion.
Our oath:
Safer, consistent medications.
Shake on it.
THE FUTURE OF COMPOUNDING IS HERE! • • • •
Traditionally compounded medication from a 503B MANUFACTURER Available for unlimited hospital administration and dispensing* Manufactured following cGMP, the same regulations used by pharmaceutical companies Largest portfolio of 503B drugs for animal health
For a list of available drugs, visit
epicurpharma.com
®
888.508.5032 *Federal law allows dispensing and administration - FDA Federal SEC. 503B. [21 U.S.C. 353b]
18
